Literature DB >> 20398869

Stunning and cumulative left ventricular dysfunction occurs late after coronary balloon occlusion in humans insights from simultaneous coronary and left ventricular hemodynamic assessment.

Stephen P Hoole1, Patrick M Heck, Paul A White, Philip A Read, Sadia N Khan, Nick E J West, Michael O'Sullivan, David P Dutka.   

Abstract

OBJECTIVES: We aimed to investigate whether left ventricular (LV) stunning could be detected late after coronary occlusion when coronary flow has normalized.
BACKGROUND: Stunning and cumulative LV dysfunction after ischemia reperfusion has been clearly demonstrated in animal models but has been refuted in several angioplasty models in humans. However, these studies have assessed LV function early, during the reactive hyperemic phase, which might have augmented LV function.
METHODS: We recruited 20 male subjects with single-vessel, type A coronary disease, and normal ventricular function. We simultaneously measured LV function with a conductance catheter and coronary flow velocity with a Combowire (Volcano Therapeutics, Inc., Rancho Cordova, California) at baseline (BL), for 30 s after a low-pressure coronary balloon occlusion for 1 min and again after 30 min, before a second balloon occlusion.
RESULTS: Stunning was detected at 30 min after a 1-min balloon occlusion: stroke volume (ml) BL1: 88.4 (22.8) versus BL2: 79.4 (24.0), p = 0.04; tau (ms) BL1: 49.8 (9.0) versus BL2: 52.5 (8.9), p = 0.02, despite full recovery of coronary average peak velocity (p = 0.62). A second balloon occlusion caused cumulative LV dysfunction: stroke volume (ml) BO1: 77.3 (34.6) versus BO2 64.9 (22.9), p = 0.01. Reactive hyperemia significantly augmented early recovery systolic function: dP/dt max 30 s: +5.8% versus 30 min - 5.4%, p = 0.0009.
CONCLUSIONS: Coronary occlusion for 1-min results in late stunning and cumulative LV dysfunction after 30 min. Reactive hyperemia augments stunned LV systolic function in early recovery. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20398869     DOI: 10.1016/j.jcin.2009.12.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  10 in total

Review 1.  Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling.

Authors:  John M Canty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-05-13       Impact factor: 5.125

2.  Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter.

Authors:  Colm McCabe; Paul A White; Stephen P Hoole; Richard G Axell; Andrew N Priest; Deepa Gopalan; Dolores Taboada; Robert MacKenzie Ross; Nicholas W Morrell; Leonard M Shapiro; Joanna Pepke-Zaba
Journal:  J Appl Physiol (1985)       Date:  2013-12-19

Review 3.  Myocardial stunning and hibernation revisited.

Authors:  Gerd Heusch
Journal:  Nat Rev Cardiol       Date:  2021-02-02       Impact factor: 32.419

4.  Predictors and prognostic impact of left ventricular ejection fraction trajectories in patients with ST-segment elevation myocardial infarction.

Authors:  Zhijun Lei; Bingyu Li; Bo Li; Wenhui Peng
Journal:  Aging Clin Exp Res       Date:  2022-02-11       Impact factor: 4.481

5.  Stunning and Right Ventricular Dysfunction Is Induced by Coronary Balloon Occlusion and Rapid Pacing in Humans: Insights From Right Ventricular Conductance Catheter Studies.

Authors:  Richard G Axell; Joel P Giblett; Paul A White; Andrew Klein; James Hampton-Til; Michael O'Sullivan; Denise Braganza; William R Davies; Nick E J West; Cameron G Densem; Stephen P Hoole
Journal:  J Am Heart Assoc       Date:  2017-06-06       Impact factor: 5.501

6.  GLP-1 Is a Coronary Artery Vasodilator in Humans.

Authors:  Sophie J Clarke; Joel P Giblett; Lucy L Yang; Annette Hubsch; Tian Zhao; Muhammad Aetesam-Ur-Rahman; Nick E J West; Michael O'Sullivan; Nichola Figg; Martin Bennett; Nicolai J Wewer Albrechtsen; Carolyn F Deacon; Joseph Cheriyan; Stephen P Hoole
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

7.  Glucagon-Like Peptide-1-Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion.

Authors:  Joel P Giblett; Richard G Axell; Paul A White; Muhammad Aetesam-Ur-Rahman; Sophie J Clarke; Nicola Figg; Martin R Bennett; Nick E J West; Stephen P Hoole
Journal:  JACC Basic Transl Sci       Date:  2019-04-29

Review 8.  Invasive left ventricle pressure-volume analysis: overview and practical clinical implications.

Authors:  Marcelo B Bastos; Daniel Burkhoff; Jiri Maly; Joost Daemen; Corstiaan A den Uil; Koen Ameloot; Mattie Lenzen; Felix Mahfoud; Felix Zijlstra; Jan J Schreuder; Nicolas M Van Mieghem
Journal:  Eur Heart J       Date:  2020-03-21       Impact factor: 29.983

9.  GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated.

Authors:  Muhammad Aetesam-Ur-Rahman; Joel P Giblett; Bharat Khialani; Stephen Kyranis; Sophie J Clarke; Tian X Zhao; Denise M Braganza; Sarah C Clarke; Nick E J West; Martin R Bennett; Stephen P Hoole
Journal:  BMC Cardiovasc Disord       Date:  2021-05-01       Impact factor: 2.174

10.  Coronary Flow Variations Following Percutaneous Coronary Intervention Affect Diastolic Nonhyperemic Pressure Ratios More Than the Whole Cycle Ratios.

Authors:  Muhammad Aetesam-Ur-Rahman; Tian X Zhao; Kitty Paques; Joana Oliveira; Bharat Khialani; Stephen Kyranis; Denise M Braganza; Sarah C Clarke; Martin R Bennett; Nick E J West; Stephen P Hoole
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.